Climara combined with Premarin

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Stress Required Intervention 7/10/2000 62 Female 144 lb 1/13/2006 Physician United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 8/23/2002 61 Female 150 lb 1/16/2006 United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 1/14/2002 54 Female 1/31/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 8/23/2002 61 Female 150 lb 1/26/2006 United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 2/1/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/16/2001 49 Female 125 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 6/1/2003 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/20/2004 Female 12/23/2005 United States
Primary
Secondary
Rheumatoid Arthritis Hospitalization 1/22/2001 51 Female 145 lb 2/9/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/1999 48 Female 12/23/2005 United States
Primary
Secondary
Stress Required Intervention 7/10/2000 62 Female 144 lb 2/21/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/25/2002 Female 2/28/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/25/2002 Female 3/1/2006 United States
Primary
Secondary
Stress Required Intervention 7/10/2000 62 Female 144 lb 3/6/2006 Physician United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 4/25/1997 61 Female 3/17/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/2/2001 64 Female 4/11/2006 Lawyer United States
Primary
Secondary
Smear Cervix Abnormal Other Serious 5/9/2002 54 Female 153 lb 4/5/2006 Lawyer United States
Primary
Secondary
Concomitant
Weight Increased Hospitalization 10/13/1998 56 Female 172 lb 4/5/2006 Physician United States
Primary
Secondary
Concomitant
Stress Required Intervention 7/10/2000 62 Female 144 lb 4/7/2006 Physician United States
Primary
Secondary
Concomitant
Ovarian Cancer Other Serious 5/9/2002 Female 2/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 2/8/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/2/2001 64 Female 4/12/2006 United States
Primary
Secondary
Wound Infection Other Serious 1/1/2000 64 Female 4/24/2006 Physician United States
Primary
Concomitant
Neoplasm Malignant Other Serious 12/14/1995 54 Female 190 lb 4/18/2006 Physician United States
Primary
Secondary
Concomitant
Vomiting Other Serious 7/9/2002 77 Female 130 lb 4/21/2006 United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 4/21/2006 Physician United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 4/25/1997 61 Female 4/27/2006 United States
Primary
Secondary
Concomitant
Menopausal Symptoms Other Serious 5/1/1997 55 Female 182 lb 5/2/2006 Pharmacist United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Required Intervention 7/10/2000 62 Female 144 lb 5/3/2006 Physician United States
Primary
Secondary
Concomitant
Vaginal Infection Hospitalization 8/1/2000 50 Female 145 lb 5/18/2006 Physician United States
Primary
Secondary
Concomitant
Wound Necrosis Hospitalization 8/1/2000 50 Female 145 lb 5/24/2006 Physician United States
Primary
Secondary
Concomitant
Thrombosis Other Serious 1/1/1996 45 Female 5/31/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 6/8/2006 Consumer United States
Primary
Secondary
Ovarian Cancer Other Serious 1/1/2003 Female 161 lb 6/8/2006 Consumer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 6/1/2006 Physician United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 8/23/2002 61 Female 150 lb 6/2/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/25/1997 62 Female 6/2/2006 United States
Primary
Secondary
Concomitant
Weight Increased Hospitalization 8/1/2000 50 Female 145 lb 6/8/2006 Physician United States
Primary
Secondary
Concomitant
Ultrasound Scan Abnormal Other Serious 11/20/2002 48 Female 148 lb 6/12/2006 Physician United States
Primary
Secondary
Concomitant
Wound Necrosis Hospitalization 8/1/2000 50 Female 145 lb 6/13/2006 Physician United States
Primary
Secondary
Concomitant
Thyroid Disorder Other Serious 12/1/1999 48 Female 139 lb 6/14/2006 Lawyer United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Required Intervention 7/10/2000 62 Female 144 lb 6/16/2006 Physician United States
Primary
Secondary
Concomitant
Polytraumatism Other Serious 1/1/1998 51 Female 135 lb 6/15/2006 Lawyer United States
Primary
Secondary
Pulmonary Embolism Other Serious 4/25/1997 61 Female 6/16/2006 Lawyer United States
Primary
Secondary
Concomitant
Salpingo-oophorectomy Other Serious 1/1/1998 51 Female 135 lb 6/19/2006 Physician United States
Primary
Secondary
Tricuspid Valve Incompetence Other Serious 8/23/2002 61 Female 150 lb 6/21/2006 United States
Primary
Secondary
Uterine Leiomyoma Hospitalization 5/9/2002 54 Female 153 lb 6/29/2006 Lawyer United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 6/12/2003 63 Female 180 lb 6/22/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/2005 Female 7/12/2006 Lawyer United States
Primary
Secondary
Pharmaceutical Product Complaint Other Serious 3/1/2004 49 Female 245 lb 7/7/2006 Lawyer United States
Primary
Concomitant
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 162 lb 7/12/2006 Lawyer United States
Primary
Secondary
Concomitant
Epilepsy Other Serious 3/23/2006 44 Female 97 lb 6/12/2006 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Required Intervention Female 6/15/2006 Lawyer United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 162 lb 7/26/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 6/2/2001 64 Female 7/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Required Intervention 1/14/2002 54 Female 145 lb 7/7/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 7/1/2003 Female 7/7/2006 United States
Primary
Secondary
Thyroid Disorder Other Serious 9/1/1999 48 Female 139 lb 7/31/2006 Physician United States
Primary
Secondary
Breast Cancer Female Other Serious 7/1/2004 59 Female 8/9/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 Female 8/17/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2004 53 Female 9/5/2006 Consumer United States
Primary
Secondary
Pain In Extremity Other Serious 10/1/1999 74 Female 119 lb 9/5/2006 Physician United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/2004 53 Female 9/5/2006 United States
Primary
Secondary
Thrombosis Other Serious 11/1/2001 41 Female 113 lb 9/5/2006 Lawyer United States
Primary
Secondary
Pharmaceutical Product Complaint Other Serious 41 Female 201 lb Other Health Professional United States
Primary
Secondary
Splenic Lesion Other Serious 4/25/1997 61 Female 10/5/2006 United States
Primary
Secondary
Concomitant
Pulmonary Embolism Other Serious 4/25/1997 61 Female 10/31/2006 United States
Primary
Secondary
Concomitant
Ventricular Dysfunction Other Serious 4/25/1997 61 Female 11/15/2006 United States
Primary
Secondary
Concomitant
Weight Increased Hospitalization 8/1/2000 50 Female 145 lb 12/28/2006 Physician United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 6/2/2001 Female 156 lb 12/30/2006 United States
Primary
Secondary
Thrombosis Other Serious 1/1/1996 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2004 53 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2002 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2003 48 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2005 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 51 Female 145 lb 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2001 51 Female 140 lb 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 48 Female 10/10/2006 United States
Primary
Secondary
Injury Other Serious 10/1/2001 Female 9/18/2006 Lawyer United States
Primary
Secondary
Uterine Leiomyoma Other Serious 5/28/1997 62 Female 145 lb 1/26/2007 Consumer United States
Primary
Secondary
Vena Cava Thrombosis Hospitalization 3/24/1999 55 Female 157 lb 1/25/2007 United States
Primary
Secondary
Pharmaceutical Product Complaint Other Serious 5/9/2002 Female 153 lb 2/8/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 6/1/2001 Female 165 lb 2/22/2007 United States
Primary
Secondary
Concomitant
Respiratory Failure Other Serious 1/1/1998 53 Female 200 lb 2/23/2007 Consumer United States
Primary
Secondary
Concomitant
Vertigo Other Serious 1/1/1980 56 Female 118 lb 3/8/2007 United States
Primary
Secondary
Concomitant
Mastectomy Other Serious 1/25/2002 Female 11/3/2006 Lawyer United States
Primary
Secondary
Scar Other Serious Female 10/30/2006 Lawyer United States
Primary
Secondary
Scar Other Serious Female 10/30/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1999 48 Female 130 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2001 54 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2000 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/30/2000 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/20/2004 61 Female 122 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2004 59 Female 12/22/2006 United States
Primary
Secondary
Uterine Leiomyoma Other Serious 9/4/1992 64 Female 192 lb 4/14/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/25/2002 Female 1/31/2007 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 Female 2/7/2007 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/2004 53 Female 2/7/2007 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2001 53 Female 2/7/2007 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 9/4/2003 51 Female 128 lb 2/7/2007 Pharmacist United States
Primary
Secondary
Concomitant
Breast Cancer In Situ Other Serious 12/27/2001 56 Female 138 lb 2/7/2007 Physician United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2000 59 Female 156 lb 2/7/2007 Lawyer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/2001 48 Female 134 lb 2/7/2007 Lawyer United States
Primary
Secondary
Concomitant
Irritable Bowel Syndrome Other Serious 7/7/1998 65 Female 185 lb 2/7/2007 Physician United States
Primary
Secondary
Concomitant
Procedural Pain Other Serious 1/1/2003 57 Female 150 lb 2/7/2007 Lawyer United States
Primary
Secondary
Concomitant
Radical Mastectomy Other Serious 7/24/2002 56 Female 5/22/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary

Drug Data